Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label pragmatic study of an all-oral short-course bedaquiline-containing regimen in Chinese patients with multidrug-resistant pulmonary tuberculosis
CTR20220808Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bedaquiline in pulmonary tuberculosis (TB), sponsored by Janssen Pharmaceutical. Started Jun 2022; status: completed.
02
Drugs
bedaquiline
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on CTR20220808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220808.